InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Barry John Joseph, Vice-Président de la R&D. Officer active across 1 company, notably Miromatrix Medical Inc.. In total, 5 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 1 October 2021. The latest transaction was disclosed on 10 March 2023 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Barry John Joseph
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
6,250 shares@ US$1.6073.5% of flowCommon StockSEC:0001415889-23-005635:0
Canonical exit: 8 Jun 2023 (T+90)
10,000 shares0Common StockSEC:0001415889-23-001094:0
765 shares@ US$4.3826.5% of flowCommon StockSEC:0001415889-22-010289:0
10,000 shares0Common StockSEC:0001415889-22-000636:0
10,000 shares0Common StockSEC:0001179110-21-009182:0
5 of 5 declarations
About Barry John Joseph
John Joseph Barry is the Vice President of R&D at Miromatrix Medical Inc. He oversees the company's research and development initiatives, playing a key role in innovation and advancement in medical technologies.
